ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Arbutus Biopharma (ABUS)

Technical Analysis Report for USA stock ABUS Arbutus Biopharma. Dated: 09 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma then click here. or read Experts views on Arbutus Biopharma or Forecast & share price targets of Arbutus Biopharma

Arbutus Biopharma Opened at 4.69 and Closed at: 4.62, which is -0.65% of previous session's close. It moved within a range of 4.59 and 4.73
The session was a Bearish session with an average volume of 902000, which is -51.84% of previous session's volumes.

    Support for tomorrow is 4.54 and resistance for tomorrow is 4.68
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 4.56, 4.51 resistance for tomorrow's hourly charts is 4.7, 4.79

    10 Day SMA for Arbutus Biopharma (ABUS) is 4.74 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Arbutus Biopharma (ABUS) is 4.7 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Arbutus Biopharma (ABUS) is 4.57 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 4.4 and the stock is trading above these levels. This is a good sign for its long term trend

    200 Day SMA Arbutus Biopharma is 3.85 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Arbutus Biopharma is at 4.7 and 200 DMA is at 3.85, while 50 DMA and 100 DMA are at 4.57 and 4.4 respectively

    Arbutus Biopharma (ABUS) moving average of 20 SMA is at 4.7 and 20 EMA is at 4.67

    Arbutus Biopharma (ABUS) moving average of 50 SMA is at 4.57 and 50 EMA is at 4.55

    Arbutus Biopharma (ABUS) moving average of 100 SMA is at 4.4 and 100 EMA is at 4.38

    Arbutus Biopharma (ABUS) moving average of 200 SMA is at 3.85 and 200 EMA is at 4.18

    Qiagen N has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Qiagen N, about 7.34% more returns!

    Arbutus Biopharma has performed better than 3m Company in short term. Holding Arbutus Biopharma could be a better choice for now!

    Spero Therapeutics has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Spero Therapeutics, about 9.58% more returns!

    Redhill Biopharma has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Redhill Biopharma, about 7.74% more returns!

    Pulse Biosciences has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Pulse Biosciences, about 6.09% more returns!

    Petmed Express has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Petmed Express, about 12.48% more returns!

    Arbutus Biopharma has performed better than Immuron in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Galmed Pharmaceuticals in short term. Holding Arbutus Biopharma could be a better choice for now!

    Fonar Corporation has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Fonar Corporation, about 25.9% more returns!

    Arbutus Biopharma has performed better than Establishment Labs in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Diamedica Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!

    Cumberland Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 99.87% more returns!

    Arbutus Biopharma has performed better than Collegium Pharmaceutical in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Bioxcel Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Accuray Incorporated in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma has performed better than Agenus Inc in short term. Holding Arbutus Biopharma could be a better choice for now!

    Arbutus Biopharma Technical analysis of indicators

    Price action analysis of Arbutus Biopharma (ABUS) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

    ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.

    Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

    Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

    CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in positive zone. This is a BUY zone

    Stock of Arbutus Biopharma is picking up buying momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 4.75 and Arbutus Biopharma ABUS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Arbutus Biopharma ABUS stock. Volume based technical analysis of Arbutus Biopharma ABUS stock is negative.

    Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And ABUS Experts View which covers a lot of information including buying and selling signals

    ABUS future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arbutus Biopharma or View Candle Stick Charts here

    Chart Arbutus Biopharma (ABUS)  Technical (Analysis) Reports Arbutus Biopharma [

    Videos related to: Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Arbutus Biopharma (ABUS)  Technical (Analysis) Reports Arbutus Biopharma [

     

    Back to top